Premarket Movers | Revolution Medicines Jumps 16%; Tilray Gains 7%; Semiconductor Equipment Shares Jump With ASML Up 3%; AXT Falls 13% on Lowered Sales Outlook
Tiger Newspress01-09 17:28
Revolution Medicines, Inc. jumped over 16% in premarket trading as Merck is in talks to buy it, the Financial Times reported on Thursday, citing people familiar with the matter.
Semiconductor equipment shares jumped in premarket trading with ASML up 3%, Lam Research up 1.3%.
AXT shares dropped after the company cut its revenue outlook, citing China's reduction of export control permits. The stock shed 13% to $22.45 in premarket trading. Through the close, shares were up nearly fivefold over the past three months.
Tilray Inc. rose 7% in premarket trading after announcing a potential rescheduling of marijuana in the U.S. could boost its medical cannabis business.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
